204 related articles for article (PubMed ID: 14984003)
1. Enalapril improves vascular and cardiac function in streptozotocin-diabetic rats.
Crespo MJ; Dunbar DC
Cell Mol Biol (Noisy-le-grand); 2003 Dec; 49(8):1311-8. PubMed ID: 14984003
[TBL] [Abstract][Full Text] [Related]
2. Enalapril improves impairment of SERCA-derived relaxation and enhancement of tyrosine nitration in diabetic rat aorta.
Taguchi K; Kobayashi T; Hayashi Y; Matsumoto T; Kamata K
Eur J Pharmacol; 2007 Feb; 556(1-3):121-8. PubMed ID: 17196960
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of enalapril on vascular reactivity of the rat aorta.
Baluchnejadmojarad T; Roghani M; Imani A
Vascul Pharmacol; 2004 Jan; 40(6):301-7. PubMed ID: 15063834
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
5. Low-dose enalapril reduces angiotensin II and attenuates diabetic-induced cardiac and autonomic dysfunctions.
Malfitano C; De Angelis K; Fernandes T; Wichi RB; Rosa K; Pazzine M; Mostarda C; Ronchi FA; Oliveira EM; Casarini DE; Irigoyen MC
J Cardiovasc Pharmacol; 2012 Jan; 59(1):58-65. PubMed ID: 21921804
[TBL] [Abstract][Full Text] [Related]
6. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned?
Erman A; Boner G; van Dijk DJ
J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):365-8. PubMed ID: 11967825
[TBL] [Abstract][Full Text] [Related]
7. Renal vascular responsiveness to angiotensin II at an early stage of diabetes: interaction between intrarenal noradrenergic and renin-angiotensin systems.
García VM; Monasterolo LA; Elías MM
Acta Diabetol; 2003 Sep; 40(3):130-6. PubMed ID: 14605969
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular deterioration in STZ-diabetic rats: possible role of vascular RAS.
Crespo MJ; Moreta S; González J
Pharmacology; 2003 May; 68(1):1-8. PubMed ID: 12660473
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of ACE inhibitors on vascular endothelial dysfunction induced by exogenous advanced oxidation protein products in rats.
Chen SX; Song T; Zhou SH; Liu YH; Wu SJ; Liu LY
Eur J Pharmacol; 2008 Apr; 584(2-3):368-75. PubMed ID: 18334254
[TBL] [Abstract][Full Text] [Related]
10. Metformin reduces blood pressure and restores endothelial function in aorta of streptozotocin-induced diabetic rats.
Majithiya JB; Balaraman R
Life Sci; 2006 Apr; 78(22):2615-24. PubMed ID: 16318863
[TBL] [Abstract][Full Text] [Related]
11. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
[TBL] [Abstract][Full Text] [Related]
12. Chronic salt loading and cardiovascular-associated changes in experimental diabetes in rats.
Maeda C; Schaan B; Oliveira E; Oliveira V; De Angelis K; Irigoyen M
Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):574-80. PubMed ID: 17581211
[TBL] [Abstract][Full Text] [Related]
13. Increased serum angiotensin-converting enzyme activity and plasma angiotensin II levels during pregnancy and postpartum in the diabetic rat.
van Dijk DJ; Boner G; Giler S; Erman A
J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):193-8. PubMed ID: 11881122
[TBL] [Abstract][Full Text] [Related]
14. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE
Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
[TBL] [Abstract][Full Text] [Related]
15. Disparate effects of angiotensin converting enzyme inhibitor and calcium blocker treatment on the preservation of renal structure and function following subtotal nephrectomy or streptozotocin-induced diabetes in the rat.
Jackson B; Cubela R; Debrevi L; Whitty M; Johnston CI
J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S167-9. PubMed ID: 2455124
[TBL] [Abstract][Full Text] [Related]
16. Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats.
Komers R; Schutzer W; Xue H; Oyama TT; Lindsley JN; Anderson S
Transl Res; 2007 Dec; 150(6):343-9. PubMed ID: 18022596
[TBL] [Abstract][Full Text] [Related]
17. Nerve conduction velocity and evoked potential latencies in streptozotocin-diabetic rats: effects of treatment with an angiotensin converting enzyme inhibitor.
Manschot SM; Gispen WH; Kappelle LJ; Biessels GJ
Diabetes Metab Res Rev; 2003; 19(6):469-77. PubMed ID: 14648806
[TBL] [Abstract][Full Text] [Related]
18. Interaction between AT1 and alpha1-adrenergic receptors in cardiomyopathic hamsters.
Crespo MJ
J Card Fail; 2000 Sep; 6(3):257-63. PubMed ID: 10997753
[TBL] [Abstract][Full Text] [Related]
19. Effects of L-carnitine treatment on oxidant/antioxidant state and vascular reactivity of streptozotocin-diabetic rat aorta.
Irat AM; Aktan F; Ozansoy G
J Pharm Pharmacol; 2003 Oct; 55(10):1389-95. PubMed ID: 14607021
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition.
Navarro JF; Milena FJ; Mora C; León C; Claverie F; Flores C; García J
Kidney Int Suppl; 2005 Dec; (99):S98-102. PubMed ID: 16336586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
